Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET

被引:4
|
作者
Hardie, RJ [1 ]
机构
[1] Atkinson Morleys Hosp, Reg Neurosci Unit, Wolfson Neurorehabil Ctr, St Georges Healthcare, London SW20 0NE, England
来源
关键词
D O I
10.1136/jnnp.66.2.256
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [1] Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET
    Morrish, PK
    Rakshi, JS
    Bailey, DL
    Sawle, GV
    Brooks, DJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03): : 314 - 319
  • [2] The rate of progression in Parkinson's disease:: A [18F]dopa PET study
    Nurmi, EM
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Rinne, JO
    [J]. NEUROLOGY, 1999, 52 (06) : A91 - A91
  • [3] Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study
    Nurmi, E
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Sonninen, P
    Rinne, JO
    [J]. MOVEMENT DISORDERS, 2001, 16 (04) : 608 - 615
  • [4] The rate of progression of Parkinson's disease - A longitudinal [F-18]DOPA PET study
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    [J]. PARKINSON'S DISEASE, 1996, 69 : 427 - 431
  • [5] Tremor at diagnosis is predictive of slower disease progression in Parkinson's disease:: An 18F DOPA PET study
    Whone, AL
    Brefel-Courbon, C
    Moore, RY
    Rascol, O
    Brooks, DJ
    [J]. MOVEMENT DISORDERS, 2002, 17 : S140 - S141
  • [6] An [F-18]dopa-PET and clinical study of the rate of progression in Parkinson's disease
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    [J]. BRAIN, 1996, 119 : 585 - 591
  • [7] Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
    V. Kaasinen
    R. P. Maguire
    H.–P. Hundemer
    K. L. Leenders
    [J]. Journal of Neurology, 2006, 253 : 340 - 348
  • [8] Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
    Kaasinen, V
    Maguire, RP
    Hundemer, HP
    Leenders, KL
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 (03) : 340 - 348
  • [9] Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
    Pavese, Nicola
    Rivero-Bosch, Maria
    Lewis, Stephanie J.
    Whone, Alan L.
    Brooks, David J.
    [J]. NEUROIMAGE, 2011, 56 (03) : 1463 - 1468
  • [10] Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-Dopa PET study
    Pavese, N.
    Rivero-Bosch, M.
    Lewis, S. J.
    Brooks, D. J.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S154 - S154